CATALOGO DEI PRODOTTI DELLA RICERCA

Ciccarese, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.714
NA - Nord America 2.634
AS - Asia 1.910
SA - Sud America 249
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 71
OC - Oceania 1
Totale 7.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.554
RU - Federazione Russa 1.050
SG - Singapore 694
GB - Regno Unito 651
CN - Cina 617
IT - Italia 257
BR - Brasile 184
SE - Svezia 182
VN - Vietnam 175
IE - Irlanda 147
HK - Hong Kong 144
DE - Germania 130
FR - Francia 113
KR - Corea 58
FI - Finlandia 53
BD - Bangladesh 41
CA - Canada 37
IN - India 37
AR - Argentina 29
MX - Messico 29
NL - Olanda 25
PL - Polonia 25
JP - Giappone 23
TR - Turchia 23
NG - Nigeria 20
ID - Indonesia 18
ZA - Sudafrica 15
ES - Italia 13
UA - Ucraina 13
EC - Ecuador 12
IQ - Iraq 12
MA - Marocco 11
BE - Belgio 9
AT - Austria 7
LT - Lituania 7
PH - Filippine 7
PK - Pakistan 7
VE - Venezuela 7
AZ - Azerbaigian 6
MY - Malesia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
KE - Kenya 5
PY - Paraguay 5
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
EU - Europa 4
SA - Arabia Saudita 4
AL - Albania 3
EG - Egitto 3
GR - Grecia 3
GT - Guatemala 3
JM - Giamaica 3
JO - Giordania 3
LK - Sri Lanka 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
BG - Bulgaria 2
CR - Costa Rica 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MW - Malawi 1
NE - Niger 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 7.577
Salva come PNG Salva come JPEG
Città #
Southend 609
Singapore 358
Moscow 356
Ashburn 332
Chandler 300
San Jose 265
Dallas 175
Beijing 147
Dublin 147
Hong Kong 143
Woodbridge 105
The Dalles 98
Council Bluffs 89
Verona 75
Ann Arbor 74
Los Angeles 70
New York 61
Houston 60
Ho Chi Minh City 48
Lawrence 46
Princeton 46
Jacksonville 45
Nanjing 42
Wilmington 38
Hanoi 31
Jinan 31
São Paulo 31
Santa Clara 28
Shenyang 26
Montreal 22
Abuja 20
Buffalo 20
Redondo Beach 20
Columbus 19
Hebei 19
Tokyo 19
Denver 17
Munich 17
Brooklyn 16
Helsinki 16
Tianjin 16
Changsha 15
Milan 14
Redwood City 14
Chicago 13
Dong Ket 13
Frankfurt am Main 13
Guangzhou 13
Haikou 13
Sindelfingen 13
Zhengzhou 13
Stockholm 12
Warsaw 12
Johannesburg 11
London 11
Mexico City 11
Jakarta 10
Orem 10
Seoul 10
Taizhou 10
Amsterdam 9
Boston 9
Da Nang 9
Jiaxing 9
Bologna 8
Brussels 8
Dearborn 8
Ningbo 8
Norwalk 8
Rome 8
Biên Hòa 7
Chennai 7
Dhaka 7
Fuzhou 7
Kent 7
Nanchang 7
Phoenix 7
Seattle 7
Vienna 7
Ankara 6
Baku 6
Campinas 6
Hangzhou 6
Lanzhou 6
San Francisco 6
Taiyuan 6
Tashkent 6
Turku 6
Haiphong 5
Istanbul 5
Krakow 5
New Delhi 5
Paris 5
Atlanta 4
Bussolengo 4
Casablanca 4
Catanzaro 4
Detroit 4
Fairfield 4
Falkenstein 4
Totale 4.582
Salva come PNG Salva come JPEG
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 250
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 236
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 218
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 218
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 213
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 205
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 204
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 195
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 194
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 192
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 190
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 189
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 188
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 188
AR-V7 and prostate cancer: The watershed for treatment selection? 184
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 182
The development of PARP as a successful target for cancer therapy 181
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 177
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 175
2015 and human cancer: back to overall survival 172
Metabolic phenotype of bladder cancer 167
Metabolic alterations in renal cell carcinoma 167
The route to personalized medicine in bladder cancer: where do we stand? 165
Inside the 2015 ASCO Genitourinary Cancers Symposium 160
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 155
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 155
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer 154
Bladder cancer: molecular determinants of personalized therapy 154
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice 154
Metabolic Alterations in Renal and Prostate Cancer 151
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer 150
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer 149
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 146
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 142
Acquired hemophagocytic syndrome: comment to the case report 140
Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR? 133
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 131
Emerging Immunotargets in Bladder Cancer 131
Kidney cancer and 2014: is innovation really over? 130
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis 124
Role of STAT3 pathway in genitourinary tumors 114
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 112
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 104
Tp53 and its potential therapeutic role as a target in bladder cancer 103
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer 93
The prospect of precision therapy for renal cell carcinoma 92
Present and future of personalized medicine in adult genitourinary tumors 74
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 64
Totale 7.665
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.206
article - articoli 26.206
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022267 0 66 2 32 23 8 3 21 10 8 11 83
2022/2023827 54 96 72 136 59 221 2 62 93 11 17 4
2023/2024357 13 34 25 32 75 36 10 39 5 18 60 10
2024/20251.019 48 54 51 234 27 37 23 20 199 47 87 192
2025/20263.512 220 162 212 707 898 216 266 163 316 216 52 84
2026/202792 24 68 0 0 0 0 0 0 0 0 0 0
Totale 7.665